Cargando…
Nanoscale polysaccharide derivative as an AEG-1 siRNA carrier for effective osteosarcoma therapy
BACKGROUND: Nanomedicine, which is the application of nanotechnology in medicine to make medical diagnosis and treatment more accurate, has great potential for precision medicine. Despite some improvements in nanomedicine, the lack of efficient and low-toxic vectors remains a major obstacle. OBJECTI...
Autores principales: | Wang, Fen, Pang, Jia-Dong, Huang, Lei-lei, Wang, Ran, Li, Dan, Sun, Kang, Wang, Lian-tang, Zhang, Li-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811182/ https://www.ncbi.nlm.nih.gov/pubmed/29467575 http://dx.doi.org/10.2147/IJN.S147747 |
Ejemplares similares
-
Nanoscale Particles for Lung Delivery of siRNA
por: Nascimento, T.L., et al.
Publicado: (2012) -
EFEMP1 promotes the migration and invasion of osteosarcoma via MMP-2 with induction by AEG-1 via NF-κB signaling pathway
por: Wang, Zhuo, et al.
Publicado: (2015) -
PolyMetformin combines carrier and anticancer activities for in vivo siRNA delivery
por: Zhao, Yi, et al.
Publicado: (2016) -
AEG-1 associates with metastasis in papillary thyroid cancer through upregulation of MMP2/9
por: Huang, Lei-Lei, et al.
Publicado: (2017) -
Research progress on siRNA delivery with nonviral carriers
por: Gao, Yan, et al.
Publicado: (2011)